Shikari® Anti-Rituximab ELISA Kit

$1,330.00

The Shikari® Anti-Rituximab ELISA Kit is intended for the quantitative determination of antibodies to of Rituximab in serum and plasma with confirmation. The Shikari® Anti-Rituximab ELISA Kit is for Research Use Only and not for diagnostic procedures.

Anti-rituximab antibodies (ARAs) are therapeutic agents developed to recognize and neutralize rituximab, a monoclonal antibody that targets the CD20 antigen found on the surface of pre-B and mature B lymphocytes. These antibodies are used in research and clinical monitoring to evaluate the immunogenicity of rituximab treatment, which may impact therapeutic efficacy and safety. ARAs are particularly relevant in cases where patients exhibit infusion-related reactions, loss of response, or unexpected disease progression despite ongoing therapy.

In the clinical setting, anti-rituximab biomarkers serve as critical tools for therapeutic drug monitoring (TDM), enabling clinicians to measure drug levels and immune responses to optimize patient-specific dosing regimens. Monitoring the presence of ARAs can help identify non-compliance, reduced drug exposure, or increased clearance due to immune complex formation. This information guides treatment adjustments, improves outcomes, and minimizes adverse effects such as infusion reactions or B-cell rebound.

Anti-rituximab biomarkers are especially significant in autoimmune conditions and hematologic malignancies treated with rituximab, where long-term therapy may induce anti-drug antibodies (ADAs). Understanding the immunogenic profile of each patient can inform decisions on therapy continuation, switching to alternative agents, or combining treatments to minimize immune-mediated interference.

This product is manufactured in Turkey by Matriks Biotek.

Size 1 x 96 Well
Sensitivity 7.5 ng/mL
Dynamic Range 10-160 ng/mL
Incubation Time 140 minutes
Sample Type Serum, Plasma
Immunogen
Source Species
Specificity
Expression System
Clone
Group
Alpha Chain
Beta Chain
Peptide
Peptide Source
Format
Buffer
Concentration
Storage 2-8°C
Alternative Names Anti-rituximab antibodies, anti-CD20 therapeutic antibodies, rituximab-targeted immunoglobulins, rituximab-neutralizing antibodies, rituximab-binding autoantibodies, anti-rituximab immunoglobulin G, rituximab-reactive antibodies, anti-rituximab IgG response, rituximab-specific ADAs, anti-rituximab neutralizers.
Instructions For Use https://eaglebio.com/wp-content/uploads/2025/07/RIt-QNS-RM-shikari-anti-rituximab-elisa-instructions-for-use.pdf
MSDS https://eaglebio.com/wp-content/uploads/2025/07/RIt-QNS-RM-shikari-anti-rituximab-elisa-safety-data-sheet-sds.pdf

Product Citations